Clinical Trials on Lipomatosis, Multiple Symmetrical in United Kingdom
Total 4510 results
-
University of MichiganAmryt PharmaActive, not recruitingLipomatosis, Multiple SymmetricalUnited States
-
University of ArizonaLipedema FoundationUnknownLipedema | Dercum's Disease | Familial Multiple Lipomatosis | Madelung's DiseaseUnited States
-
University Hospitals Cleveland Medical CenterRecruitingLow Back Pain | LipomatosisUnited States
-
Royal Free Hampstead NHS TrustBristol-Myers Squibb; Sigma-Tau Research, Inc.Unknown
-
PerspectumRecruiting
-
Imperial College LondonGlaxoSmithKline; University College, London; Medical Research Council; Queen Mary... and other collaboratorsCompletedRelapsing-remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisUnited Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisUnited Kingdom
-
Mayo ClinicCompletedRosacea | Bilaterally Symmetric Red Skin on CheeksUnited States
-
University of GlasgowNHS Ayrshire and Arran; AKMCompletedMultiple Sclerosis, ProgressiveUnited Kingdom
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
University of LincolnNottingham University Hospitals NHS TrustCompletedDepression | Secondary-progressive Multiple SclerosisUnited Kingdom
-
University of LeicesterZimmer Biomet; British Heart Foundation; National Health Service, United KingdomWithdrawnSepsis | Inflammation | Organ Failure, MultipleUnited Kingdom
-
Oxford University Hospitals NHS TrustGleamerRecruitingFractures, Closed | Fracture | Fractures, Open | Bone Fracture | Dislocation | Fracture MultipleUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905 | Multiple DoseUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRecruiting
-
North Bristol NHS TrustUniversity of Nottingham; Medical Research Council; University of Bristol; Bristol... and other collaboratorsUnknownProgressive Multiple SclerosisUnited Kingdom
-
University of GlasgowNHS Ayrshire and Arran; AKMCompletedProgressive Multiple SclerosisUnited Kingdom
-
NHS Greater Glasgow and ClydeBiogenEnrolling by invitationRelapsing Remitting Multiple SclerosisUnited Kingdom
-
Glasgow Caledonian UniversityUnknown
-
Oxford University Hospitals NHS TrustCompletedMultiple TraumaUnited Kingdom
-
Queen Mary University of LondonMerck Sharp & Dohme LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom
-
Barts & The London NHS TrustCompletedEmergencies | Trauma Injury | Trauma, MultipleUnited Kingdom
-
Caliway Biopharmaceuticals Co., Ltd.CompletedA Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With Dercum's Disease LipomasDercum's DiseaseUnited States
-
University College London HospitalsCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Northumbria UniversityCompletedOld Age; Debility | Physical Inactivity | Chronic Conditions, MultipleUnited Kingdom
-
University College, LondonNational Multiple Sclerosis SocietyCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
University of NottinghamNottingham University Hospitals NHS TrustCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Daval International LimitedUnknownSecondary Progressive Multiple SclerosisUnited Kingdom
-
University of Texas Southwestern Medical CenterCompletedSymmetric Limited MorpheaUnited States
-
Raziel Therapeutics Ltd.CompletedDercum Disease | LipedemaUnited States
-
GlaxoSmithKlineTerminatedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Merck Serono Limited, an affiliate of Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisUnited Kingdom
-
Raziel Therapeutics Ltd.University of ArizonaCompletedDercum Disease | LipedemaUnited States
-
Trio Medicines Ltd.BiogenCompleted
-
University of NottinghamNational Multiple Sclerosis SocietyCompletedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of Sheffield; Nottingham Trent University; Sheffield Hospitals CharityRecruiting
-
The Leeds Teaching Hospitals NHS TrustActive, not recruitingWounds and Injuries | Surgery | Rehabilitation | Orthopedic Disorder | Patient Reported Outcome Measures | Disability Evaluation | Recovery of Function | Multiple Trauma/Injuries | Trauma Centers | Trauma Severity Indices | Advanced Trauma Life Support CareUnited Kingdom
-
Advanced BionicsCompletedOtorhinolaryngologic Diseases | Ear Diseases | Hearing Loss | Hearing Disorders | Asymmetrical Hearing Loss | Single-Sided DeafnessUnited States
-
Bristol-Myers SquibbCompleted
-
University of LeicesterRecruitingCoronary Artery Disease | Cardiac Valve Disease | Organ Failure, MultipleUnited Kingdom
-
University of LeicesterRecruitingCoronary Artery Disease | Cardiac Valve Disease | Organ Failure, MultipleUnited Kingdom
-
SanofiCompletedMultiple Sclerosis Healthy SubjectsUnited Kingdom
-
University College, LondonCancer Research UKRecruitingMultiple Myeloma | MGUS | Smouldering MyelomaUnited Kingdom
-
Imperial College LondonRecruiting
-
Imperial College LondonCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Riverside Haematology GroupUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
BiogenCompletedDoes Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)Relapsing Remitting Multiple SclerosisBelgium, Luxembourg, United Kingdom